These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 1324056

  • 1. Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor.
    Filep JG, Hermán F, Földes-Filep E, Schneider F, Braquet P.
    Br J Pharmacol; 1992 Apr; 105(4):912-8. PubMed ID: 1324056
    [Abstract] [Full Text] [Related]

  • 2. Platelet-activating factor may mediate dexamethasone-induced gastric damage in the rat.
    Filep J, Hermán F, Braquet P.
    Lipids; 1991 Dec; 26(12):1356-8. PubMed ID: 1819733
    [Abstract] [Full Text] [Related]

  • 3. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
    Filep JG, Sirois MG, Rousseau A, Fournier A, Sirois P.
    Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
    [Abstract] [Full Text] [Related]

  • 4. Platelet-activating factor mediates gastric damage induced by hemorrhagic shock.
    Wallace JL, Hogaboam CM, McKnight GW.
    Am J Physiol; 1990 Jul; 259(1 Pt 1):G140-6. PubMed ID: 2372058
    [Abstract] [Full Text] [Related]

  • 5. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
    László F, Whittle BJ, Moncada S.
    Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
    [Abstract] [Full Text] [Related]

  • 6. Role of PAF in the allergic pleurisy caused by ovalbumin in actively sensitized rats.
    Martins MA, Castro Faria Neto HC, Bozza PT, e Silva PM, Lima MC, Cordeiro RS, Vargaftig BB.
    J Leukoc Biol; 1993 Jan; 53(1):104-11. PubMed ID: 8381149
    [Abstract] [Full Text] [Related]

  • 7. PAF-induced death in NMRI mice--a suitable shock model for testing new PAF receptor antagonists. Correlation with eicosanoid related substances.
    Becker K, Lueddeckens G, Grupe R, Förster W.
    Prostaglandins Leukot Essent Fatty Acids; 1993 Mar; 48(3):265-71. PubMed ID: 8385779
    [Abstract] [Full Text] [Related]

  • 8. Role of leukotrienes and platelet activating factor in acute gastric mucosal lesions in rats.
    Konturek SJ, Brzozowski T, Drozdowicz D, Garlicki J, Beck G.
    Eur J Pharmacol; 1989 May 19; 164(2):285-92. PubMed ID: 2759176
    [Abstract] [Full Text] [Related]

  • 9. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists.
    Domingo MT, Piro F, Broquet C, Auclair E, Chabrier PE, Braquet P.
    Lipids; 1992 Aug 19; 27(8):582-6. PubMed ID: 1328798
    [Abstract] [Full Text] [Related]

  • 10. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists.
    Wallace JL, Steel G, Whittle BJ, Lagente V, Vargaftig B.
    Gastroenterology; 1987 Oct 19; 93(4):765-73. PubMed ID: 3305134
    [Abstract] [Full Text] [Related]

  • 11. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats.
    Teather LA, Magnusson JE, Wurtman RJ.
    Psychopharmacology (Berl); 2002 Oct 19; 163(3-4):430-3. PubMed ID: 12373444
    [Abstract] [Full Text] [Related]

  • 12. [Platelet-activating factor (PAF) antagonists].
    Terasawa M.
    Tanpakushitsu Kakusan Koso; 1991 Feb 19; 36(3):379-87. PubMed ID: 1850862
    [No Abstract] [Full Text] [Related]

  • 13. Effects of the specific platelet-activating factor antagonists, BN 52021 and BN 52063, on various experimental gastrointestinal ulcerations.
    Braquet P, Etienne A, Mencia-Huerta JM, Clostre F.
    Eur J Pharmacol; 1988 Jun 10; 150(3):269-76. PubMed ID: 3046952
    [Abstract] [Full Text] [Related]

  • 14. Protective effect of the PAF-antagonist BN 52021 on several models of gastro-intestinal mucosal damage in rats.
    Etienne A, Thonier F, Braquet P.
    Int J Tissue React; 1989 Jun 10; 11(2):59-64. PubMed ID: 2693389
    [Abstract] [Full Text] [Related]

  • 15. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.
    Biancone L, Cantaluppi V, Boccellino M, Bussolati B, Del Sorbo L, Conaldi PG, Albini A, Toniolo A, Camussi G.
    Am J Pathol; 1999 Nov 10; 155(5):1731-9. PubMed ID: 10550329
    [Abstract] [Full Text] [Related]

  • 16. Presence of specific platelet-activating factor binding sites in the rat retina.
    Thierry A, Doly M, Braquet P, Cluzel J, Meyniel G.
    Eur J Pharmacol; 1989 Apr 12; 163(1):97-101. PubMed ID: 2545464
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed.
    Dembinska-Kiec A, Peskar BA, Muller MK, Peskar BM.
    Prostaglandins; 1989 Jan 12; 37(1):69-91. PubMed ID: 2717778
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.